NFC
IMNM icon

Northeast Financial Consultants’s Immunome IMNM Stock Holding History

Northeast Financial Consultants’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$399K Hold
42,953
– – 0.02% 223
2025
Q1 		$289K Hold
42,953
– – 0.01% 244
2024
Q4 		$456K Sell
42,953
-30,000
-41% -$363K 0.02% 202
2024
Q3 		$1.07M Hold
72,953
– – 0.05% 151
2024
Q2 		$883K Buy
+72,953
New +$1.14M 0.04% 157

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northeast Financial Consultants's IMNM Position: Q2 2025 in Review

Northeast Financial Consultants held its Immunome (IMNM) position steady in Q2 2025 at 42,953 shares worth $399K. The position accounts for 0.02% of the portfolio, ranked #223.

Northeast Financial Consultants first reported a position in IMNM in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.07M in Q3 2024. 142 funds tracked by Wall St. Rank hold IMNM as of Q2 2025.

  • Northeast Financial Consultants held 42,953 shares of Immunome worth $399K as of Q2 2025.
  • Northeast Financial Consultants left its Immunome share count unchanged in Q2 2025.
  • Immunome made up 0.02% of Northeast Financial Consultants's portfolio in Q2 2025, its #223 holding.
  • Northeast Financial Consultants first reported a position in Immunome in Q2 2024 and has held it in 5 quarters since.
  • Northeast Financial Consultants's Immunome position peaked at $1.07M in Q3 2024.
  • 142 funds tracked by Wall St. Rank held Immunome as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.